Bayer to acquire Roche consumer health
Roche is to sell its consumer health business to Germany's Bayer for €2.38 billion (SF3.6 billion) in cash, the company said today.
Roche is to sell its consumer health business to Germany's Bayer for €2.38 billion (SF3.6 billion) in cash, the company said today.
The drive towards achieving better energy efficiency in UK manufacturing was given fresh impetus this week following the latest government spending review, writes Anthony Fletcher.
Major pharmaceutical and generics players are continuing to invest in plants for the production of active pharmaceutical ingredients, with Pfizer, Ivax, Berlex and Protein Design Labs all announcing new ventures in the last few days.
Packaging machinery company Thiele Technologies has launched an automatic packer system that is specifically designed for use by the pharmaceutical and food industries.
Drug development company Jerini has transferred its peptide technologies business unit to a wholly owned subsidiary which will continue to provide and develop peptide-based services and products for biomedical research.
Dutch pharmaceuticals and chemicals group Akzo Nobel has reported a small decline in sales in the first half of the year, although the cost of ongoing restructuring caused net earnings to slump by nearly a quarter to €245 million.